Volume : 10, Issue : 07, July – 2023

Title:

18.FORMULATION AND INVITRO EVALUATION OF EFFERVESCENT FLOATING TABLETS OF DOMPERIDONE

Authors :

Nandam Uma Maheswara Subbarao*, Mrs. Raj Khiani, Mrs M.Vineela

Abstract :

The present study was aimed to formulate and evaluate floating tablets of Domperidone by direct compression method. Domperidone is a dopamine antagonist medication which is used to treat nausea and vomiting and certain gastrointestinal problems like gastroparesis (delayed gastric emptying). In this study, excipients like Eudragit RSPO, HPMC, Carbopol 974P, sodium bicarbonate and Citric acid were incorporated in a nine different concentrations (F1-F9) along with other excipients (Magnesium Stearate, Talc and Micro crystalline cellulose) to formulate floating tablets by direct compression method. Then all the nine formulations were evaluated for uniformity of weight, hardness, thickness, friability test, floating lag time, drug content and dissolution studies. The dissolution profile of trial-7 (formulation 7) was observed to be better than other formulations. In trial-7 Domperidone was formulated as a floating tablet by using Carbopol 974P (32.5 mg) as a matrix forming polymer and sodium bicarbonate (10 mg) as a gas generating agent. Trial-7 formulation showed a good dissolution profile for a controlled period of time which was noticed to be as 99.29 % at the end of 12th hour. Thus, it can be concluded that the floating drug delivery system of Domperidone using the appropriate polymers in right amount may enhance the activity of the drug by prolonging the gastric residence time or reducing the floating lag time.
Key words: Domperidone, Eudragit RSPO, HPMC, Carbopol 974P and Floating Tablets.

Cite This Article:

Please cite this article in press Nandam Uma Maheswara Subbarao et al, Formulation And Invitro Evaluation Of Effervescent Floating Tablets Of Domperidone., Indo Am. J. P. Sci, 2023; 10 (07).

Number of Downloads : 10

References:

1. Pooja Gupta, Gnanarajan, Preeti Kothiyal. Floating Drug Delivery System: A Review. International Journal of Pharma Research & Review, August 2015; 4(8):37-44.
2. Shweta Arora, Floating drug delivery systems: A review AAPS Pharm SciTech.: E372–E390, Vol-6, Issue 3, September (2005).
3. GSN Koteswara Rao, KV Ramana Murthy, Aayisha Begum, B Roja Rani, Ch Ragha Naveen, B Raj Kumar, et al. Formulation and Evaluation of Floating Drug Delivery Systems of Propranolol HCl using Modified Pulsincap Technique. International Journal of Pharma Research & Review, Sept 2014; 3(9):15-22.
4. Avaru Geetha Dutt, Ande Pratyusha, Uma Maheshwar Rao, Motor Leela Keerthi, Kalakuntla Sai Krishna, Ashok Morsu. Formulation and Evaluation of Gastro Retentive Drug Delivery System of Tizanidine Hydrochloride: A Review. International Journal of Pharma Research & Review, Oct 2014; 3(10):34-45.
5. Hirtz J. The git absorption of drugs in man: review of current concepts and methods of investigation. Br J Clin Pharmacol. 1985; 19:77SY83S.
6. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery. Int J Pharm 1996; 136:117-139.
7. Gwen.M.jantezen, and Joseph.R.Robinson, Sustained and Controlled release drug delivery systems, Chapter-15, page 501-523.
8. Ponchel G, Irache JM. Specific and nonspecific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv Drug Del Rev. 1998; 34:191Y219.
9. Lenaerts VM, Gurny R. Gastrointestinal TractPhysiological variables affecting the performance of oral sustained release dosage forms. In: Lenaerts V, Gurny R, eds. Bioadhesive Drug Delivery System. Boca Raton, FL: CRC Press; 1990.
10. Garg.R and Gupta.GD., Progress in controlled gastroretentive delivery systems, Trop J Pharma Res, September 2008; 7 (3): 1055-1066.
11. Jain Amit K, Hatila Umashankar. A Review On Floating Drug Delivery System. IJPSR/Vol. II/ Issue III/July-September, 2011/01-06.
12. Vantrappen GR, Peeters TL, Janssens J. The secretory component of interdigestive migratory motor complex in man. Scand J Gastroenterol. 1979;14:663-667.
13. Wilson CG, Washington N. The stomach: its role in oral drug delivery. In: Rubinstein MH, ed. Physiological Pharmacetical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood; 1989:47-70.
14. Grubel P. et al, Gastric emptying of non-digestible solids in the fasted dog. J. Pharm. Sci. 1987, 76, 117 – 122.
15. Roop K. Khar, Controlled Drug Delivery, Gastroretentive system 4th edn.,; 202-203.
16. Khan F.N, Dehghan H.G., Int J Health Res 2009; 2(1): 23
17. 17.10.Deshpande A.A, Shah N.H, Rhodes C.T, Malick W. Pharm Res 1997; 14: 815-819
18. 18 . Davis SS, Stockwell AF, Taylor MJ. Pharm Res 1986; 3: 208-213
19. 19 . Lehr CM. Crit Rev Ther Drug Carrier Syst 1994; 11: 119-160
20. Groning R, Heun G. Drug Dev Ind Pharm 1984; 10: 527-539
21. Klausner EA, Lavy E, Friedman M, Hoffman A. J Cont Rel 2003; 90: 143-162.
22. The American Society for Gastrointestinal Endoscopy: a history Gastrointestinal Endoscopy, Volume 37, Supplement 2, March 1991, Pages S1-S26

</div8